allantoin has been researched along with Chronic Disease in 8 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Excerpt | Relevance | Reference |
---|---|---|
"Allantoin is an excellent biomarker of oxidative stress in humans as the main product of uric acid oxidation by reactive oxygen species." | 1.56 | Rapid and reliable HILIC-MS/MS method for monitoring allantoin as a biomarker of oxidative stress. ( Hasikova, L; Kalikova, K; Kozlik, P; Stiburkova, B; Zavada, J, 2020) |
"Allantoin (All) is an oxidative end product of purines in mammals." | 1.34 | Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE. ( Caussé, E; Couderc, F; Dirat, B; Negre-Salvayre, A; Pradelles, A; Salvayre, R, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Kozlik, P | 1 |
Hasikova, L | 1 |
Stiburkova, B | 1 |
Zavada, J | 1 |
Kalikova, K | 1 |
Caussé, E | 2 |
Fournier, P | 1 |
Roncalli, J | 1 |
Salvayre, R | 2 |
Galinier, M | 1 |
Pradelles, A | 1 |
Dirat, B | 1 |
Negre-Salvayre, A | 1 |
Couderc, F | 1 |
Rahamimov, R | 1 |
Klaus, S | 1 |
Tur-Kaspa, R | 1 |
Ogihara, T | 2 |
Okamoto, R | 2 |
Kim, HS | 2 |
Nagai, A | 1 |
Morinobu, T | 1 |
Moji, H | 1 |
Kamegai, H | 1 |
Hirano, K | 2 |
Ogihara, H | 2 |
Tamai, H | 2 |
Mino, M | 2 |
Imanishi, M | 1 |
Doehner, W | 1 |
Schoene, N | 1 |
Rauchhaus, M | 1 |
Leyva-Leon, F | 1 |
Pavitt, DV | 1 |
Reaveley, DA | 1 |
Schuler, G | 1 |
Coats, AJ | 1 |
Anker, SD | 1 |
Hambrecht, R | 1 |
Jacobi, KH | 1 |
1 trial available for allantoin and Chronic Disease
Article | Year |
---|---|
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
Topics: Administration, Oral; Aged; Allantoin; Allopurinol; Blood Flow Velocity; Chronic Disease; Cross-Over | 2002 |
7 other studies available for allantoin and Chronic Disease
Article | Year |
---|---|
Rapid and reliable HILIC-MS/MS method for monitoring allantoin as a biomarker of oxidative stress.
Topics: Allantoin; Biomarkers; Chromatography, High Pressure Liquid; Chronic Disease; Cohort Studies; Gout; | 2020 |
Serum allantoin and aminothiols as biomarkers of chronic heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allantoin; Biomarkers; Case-Control Studies; Chronic Dis | 2017 |
Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE.
Topics: Allantoin; Chronic Disease; Electrophoresis, Capillary; Heart Diseases; Humans; Hypoxanthine; Kidney | 2007 |
Psoriasis is not a contraindication for alpha interferon treatment in patients with chronic hepatitis C.
Topics: Adult; Allantoin; Chronic Disease; Coal Tar; Contraindications; Drug Combinations; Hepatitis C; Huma | 1995 |
New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease.
Topics: Allantoin; Chronic Disease; Female; Free Radicals; Humans; Infant, Newborn; Lung Diseases; Male; Oxy | 1996 |
Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease.
Topics: Allantoin; Ascorbic Acid; Biomarkers; Bronchoalveolar Lavage Fluid; Chronic Disease; Cohort Studies; | 1998 |
[Chronic rhinitis and its treatment].
Topics: Alcohols; Allantoin; Chronic Disease; Humans; Hydantoins; Imidazoles; Naphazoline; Naphthalenes; Nas | 1969 |